Finance ❯Market Analysis ❯Stock Performance

Investor Sentiment

Analyst Ratings Hindenburg Research Netflix Market Value Corporate Profits Earnings Forecasts Novo Nordisk Shares Economic Indicators Intel Regulatory Changes

6 ARTICLES

5mo ago

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

Intensified competition from Eli Lilly's Zepbound and compounded semaglutide products has led to flat prescriptions, underwhelming trial results, and a 25% share drop in March 2025.

8 ARTICLES

last yr.

SunPower Faces Collapse as Stock Plummets and Operations Halt